Insider · CIK 0001708764
Indrani Lall Franchini
Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.), AVNS (AVANOS MEDICAL, INC.). First filing Feb 5, 2024, latest Feb 29, 2024.
In brief
Indrani Lall Franchini files SEC Form 4 as director and officer at ALNY (ALNYLAM PHARMACEUTICALS, INC.), and also at AVNS (AVANOS MEDICAL, INC.). Since Feb 5, 2024, Indrani Lall Franchini has reported 0 open-market buys worth $0 and 2 open-market sells worth $323k, the latest filed on Feb 29, 2024.
A track record needs three past buys with six months of prices behind them; Indrani Lall Franchini has 0, so none is measured yet.
The newest scored trade: sold $51k of ALNY on Feb 28, 2024, filed Feb 29, 2024, scored 22 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALNY: ALNYLAM PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | ALNYLAM PHARMACEUTICALS, INC. | $51k 329 shares | -7% | +6% from low-27% from high | |
| 38Weak | ALNYLAM PHARMACEUTICALS, INC. | $272k 1,591 shares | -31% | +14% from low-26% from high |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | AVNS AVANOS MEDICAL, INC. | DDisposition to issuer Common Stock | -4,817 | $25.00 | $120k | 0 | Jul 28, 2026 |
| Jul 27, 2026 | AVNS AVANOS MEDICAL, INC. | DDisposition to issuer Restricted Share Unitsderivative | -12,003 | $25.00 | $300k | 0 | Jul 28, 2026 |
| May 8, 2026 | AVNS AVANOS MEDICAL, INC. | AGrant or award Restricted Share Unitsderivative | +12,003 | $0.00 | $0 | 12,003 | May 12, 2026 |
| Jan 2, 2025 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +12,003 | $0.00 | $0 | 16,820 | Jan 6, 2025 |
| Feb 27, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +878 | $0.00 | $0 | 4,462 | Feb 29, 2024 |
| Feb 28, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -142 | $154.54 | $22k | 4,320 | Feb 29, 2024 |
| Feb 28, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -111 | $155.45 | $17k | 4,209 | Feb 29, 2024 |
| Feb 28, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -66 | $156.38 | $10k | 4,143 | Feb 29, 2024 |
| Feb 28, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -9 | $157.30 | $1,416 | 4,134 | Feb 29, 2024 |
| Feb 28, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1 | $158.09 | $158 | 4,133 | Feb 29, 2024 |
| Feb 27, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -878 | $0.00 | $0 | 1,754 | Feb 29, 2024 |
| Feb 1, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +5,175 | $0.00 | $0 | 5,175 | Feb 5, 2024 |
| Feb 2, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -502 | $170.01 | $85k | 4,673 | Feb 5, 2024 |
| Feb 2, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -820 | $171.14 | $140k | 3,853 | Feb 5, 2024 |
| Feb 2, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -269 | $172.38 | $46k | 3,584 | Feb 5, 2024 |
| Feb 1, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -5,175 | $0.00 | $0 | 5,175 | Feb 5, 2024 |
Questions about Indrani Lall Franchini
Answered from the filings on this page, as of the latest one.
Is Indrani Lall Franchini buying or selling?
Not in the last 12 months. Indrani Lall Franchini's latest open-market trade on SEC Form 4 was sold $51k of ALNY on Feb 28, 2024.
How did Indrani Lall Franchini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Indrani Lall Franchini has 0.
Where does Indrani Lall Franchini file Form 4?
Indrani Lall Franchini has filed Form 4 at ALNY (ALNYLAM PHARMACEUTICALS, INC.) as EVP, CLO & Secretary; AVNS (AVANOS MEDICAL, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.